NCT01968018View on ClinicalTrials.gov

A Study of Safety and Effectiveness of Ultracet in Patients With Chronic Cancer Pain

PHASE4CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions
Cancer
Interventions
DRUG

Tramadol HCI/acetaminophen

Participants will receive tablet of tramadol HCI (37.5 mg)/acetaminophen (325 mg) on Day 1. Participants may increase their daily dosage of study medication is 1 to 2 tablets every 4 to 6 hours as needed for pain relief up to maximum of 8 tablets per day.

Trial Locations (1)

Unknown

Bangkok

All Listed Sponsors
lead

Janssen-Cilag Ltd.,Thailand

INDUSTRY

NCT01968018 - A Study of Safety and Effectiveness of Ultracet in Patients With Chronic Cancer Pain | Biotech Hunter | Biotech Hunter